Breast-conserving surgery for breast cancer is a new surgical treatment method in recent years. The aim is to achieve the same surgical treatment effect as the improved radical mastectomy through the combination of surgical treatment and postoperative consolidation treatment, including radiotherapy and chemotherapy and biological immunotherapy. Clinically, it is increasingly favored by many young female breast cancer patients.
However, breast-conserving surgery for early breast cancer is not suitable for all female friends, and it is not suitable for patients with multicenter breast cancer, oversized tumors, stage III breast cancer and tumors under areola. Breast-conserving surgery is also not suitable for patients with small breast size, high risk of local recurrence after operation and poor cosmetic effect after breast-conserving surgery.
Because breast-conserving surgery for early breast cancer needs sufficient economic ability, mainly because there are many follow-up treatments after breast-conserving surgery, in order to achieve the same therapeutic purpose as modified radical surgery, postoperative radiotherapy and chemotherapy or combined biological immunotherapy should be supplemented according to the specific conditions of patients to achieve good therapeutic effects.
Patients with early breast cancer have distant metastasis of breast cancer cells; The general condition of patients is poor, and patients with cachexia have appeared; Patients with serious diseases of heart, lung, liver, kidney and other important organs who cannot tolerate surgical treatment are not suitable for surgical treatment; It is also not suitable for surgical resection of local lesions, including skin orange peel edema, which has exceeded half of the breast area; Nodular satellite cancer focus can be seen in the skin around the main cancer focus; The tumor directly invaded the chest wall; Parasternal lymph nodes are swollen and metastasis has been confirmed; Patients with supraclavicular lymph node enlargement and metastasis confirmed by pathology are also not suitable for surgical resection.
Patients with early breast cancer who can't be treated by surgery or can't tolerate surgery can consider adopting a comprehensive treatment scheme combining radiotherapy and chemotherapy with biological immunotherapy to minimize the tumor, improve the patient's physical condition, enhance the overall treatment effect, improve the early cure rate of breast cancer and promote rehabilitation.